Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Bergen | OTHER |
| VID Specialized University | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Gynecological cancers are the sixth most common cancer forms and the number of survivors is increasing as a consequence of more efficient treatment and longer life span. As part of regulary care after cancer treatment the women have five years of follow-up with the primary focus on recurrence, aiming to increase survival. However, several studies have shown that there is no evidence for this assumption on increased survival (ref). There are now suggested alternative perspectives in the follow up period targeting late effects, health-related quality of life (QoL) and patient satisfaction with care.The main aim of the current study is to test the feasibility and acceptability of an internet-based psychosocial intervention for women treated with curative intent gynecological cancer. Another aim is to test the perceived effect on gynecological cancer survivors health-related self-care and QoL.
The study's objectives and research questions Research questions
How did the participants use the program?
What is the participants' perceived credibility of the program?
How do the participants experience the guided psychosocial digital intervention?
How is the perceived effect on the gynecological cancer survivors' competence, QoL, self-care and coping?
It is hypothesized that an internet-based psycho-social intervention will support women in developing self-competence and self-care which could be measured as increased QOL and secondarily affect the impact of cancer, distress, anxiety, depression, self-esteem, and self-reported ability to monitor and respond to symptoms of recurrence.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| GYNEA- digital coping program | Experimental | Participants randomized to this arm will receive active treatment after the inclusion |
|
| Waiting list | No Intervention | 6 weeks waiting list before crossing over to GYNEA- digital coping program |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| GYNEA- digital coping program for women after gynaecological cancer | Behavioral | 6 modules with relevant information and tools for coping after cancer |
|
| Measure | Description | Time Frame |
|---|---|---|
| The Impact of Cancer version 2 | Designed to assess the physical and psychosocial health experience of cancer survivors through its positive and negative impacts. 47-item questionnaire organized into 4 positive (altruism and empathy (AE), health awareness (HA), meaning of cancer (MOC), positive self-evaluation (PSE)) and 4 negative (appearance concerns (AC), body change concerns (BCC), life interference (LI) and worry (W)) impact dimensions [13] corresponding to the first 37 items. The questionnaire also includes 10 additional items constituting conditional dimensions applicable to subsets of survivors assessing employment concerns (EC), relationship concerns for individuals with a partner (P), and relationship concerns for those without a partner (NP). All items are scored on a five-point scale from 1 = strongly disagree to 5 = strongly agree. A higher score on a dimension implies stronger endorsement of that content area | up to 26 weeks |
| The Quality of Life Patient/Cancer Survivor Version | ordinal questionnaire measuring the quality of life in cancer patients over 42 items rated on 10 point Likert-type scale. The revised instrument included 41 items representing the four domains of quality of life incorporating physical, psychological, social, and spiritual well being. | up to 26 weeks |
| Patient Health Questionnaire | Subjects indicated for each of the nine depressive symptoms (corresponding to the criteria ofDSM-IV) whether, during the previous 2 weeks, the symptom has bothered them: 0=not at all; 1=several days; 2=more than half of the days; 3=nearly every day. | up to 26 weeks |
Not provided
Not provided
Inclusion Criteria
Exclusion Criteria:
gyneocological cancer
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Tine Nordgreen, PhD | Contact | +4790094913 | tine.nordgreen@gmail.com | |
| Ragnhild Sekse | Contact |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Bergen Municipality Division School | Recruiting | Bergen | Vestland | 5003 | Norway |
Not provided
| ID | Term |
|---|---|
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D014850 | Waiting Lists |
| ID | Term |
|---|---|
| D001071 | Appointments and Schedules |
| D009934 | Organization and Administration |
| D006298 | Health Services Administration |
Not provided
Not provided
active intervention group vs waiting list group. Waitling list group crossing over to active group after 6 weeks
Not provided
Not provided
study participants will be identified with an anonymous ID
|
| Haukeland University Hospital | Recruiting | Bergen | 5020 | Norway |
|